Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.4
edited by Sarantis Dimitriadis
on 2022/06/02 10:00
Change comment: There is no comment for this version
To version 11.2
edited by Sarantis Dimitriadis
on 2023/11/23 18:12
Change comment: Update document after refactoring.

Summary

Details

Page properties
Parent
... ... @@ -1,1 +1,1 @@
1 -Living Lab Business Model.WebHome
1 +Living Lab Business and Governance Model.WebHome
Content
... ... @@ -7,6 +7,8 @@
7 7  (% class="western" lang="en-GB" style="text-align:justify" %)
8 8  (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following:
9 9  
10 +:
11 +
10 10  * (((
11 11  (% lang="en-US" %)**Non-professional end users:**
12 12  
... ... @@ -15,6 +15,8 @@
15 15  * (% lang="en-US" %)**Public health and social service clients: **Those who use public services.
16 16  )))
17 17  
20 +:
21 +
18 18  * (((
19 19  (% lang="en-US" %)**Professional end users**
20 20  
... ... @@ -25,9 +25,13 @@
25 25  * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level.
26 26  )))
27 27  
32 +:
33 +
28 28  (% class="western" lang="en-GB" %)
29 29  (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows:
30 30  
37 +:
38 +
31 31  * (((
32 32  (% lang="en-US" %)**Private sector organizations: **(business developers and researchers)
33 33  
... ... @@ -42,6 +42,8 @@
42 42  * (% lang="en-US" %)Pharmaceutical companies
43 43  )))
44 44  
53 +:
54 +
45 45  * (((
46 46  (% lang="en-GB" %)
47 47  (% lang="en-US" %)**Public sector organizations:**
... ... @@ -57,6 +57,8 @@
57 57  * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process.
58 58  )))
59 59  
70 +:
71 +
60 60  * (((
61 61  (% lang="en-GB" %)
62 62  (% lang="en-US" %)**Education and research organizations:**
... ... @@ -70,6 +70,8 @@
70 70  * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers
71 71  )))
72 72  
85 +:
86 +
73 73  * (((
74 74  (% lang="en-GB" %)
75 75  (% lang="en-US" %)**Civil society organizations:**
... ... @@ -77,6 +77,8 @@
77 77  * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level.
78 78  )))
79 79  
94 +:
95 +
80 80  * (((
81 81  (% lang="en-GB" %)
82 82  (% lang="en-US" %)**Networks and clusters:**
... ... @@ -85,295 +85,111 @@
85 85  * (% lang="en-US" %)International, national, regional and local networks
86 86  )))
87 87  
88 -(% class="western" lang="en-GB" %)
89 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table .
104 +:
90 90  
91 -
92 -(% cellspacing="0" class="table-striped" dir="ltr" style="margin-left:auto; margin-right:auto" %)
93 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:5px; padding:0in 0.08in; width:628px" %)(((
94 -(% class="western" lang="en-GB" style="text-align:center" %)
95 -(% lang="en-US" style="font-family:Calibri,serif" %)**Age or age group**
96 -)))
97 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
98 98  (% class="western" lang="en-GB" %)
99 -(% lang="en-US" style="font-family:Calibri,serif" %)Specific age range
100 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
101 -(% class="western" %)
107 +(% lang="en-US" %)Typical approaches to define (%%)//**non-professional **//end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in the following table .
108 +
109 +(% style="margin-left:auto; margin-right:auto; width:1694px" %)
110 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups**
111 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
112 +(% lang="en-US" %)Specific age range
113 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
102 102  
103 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
115 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
104 104  (% class="western" %)
105 105  
106 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
118 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
107 107  (% class="western" %)
108 108  
109 109  )))
110 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
122 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)General Population
123 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)**
124 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
111 111  (% class="western" lang="en-GB" %)
112 -(% lang="en-US" style="font-family:Calibri,serif" %)Elderly
113 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
126 +(% lang="en-US" %)Healthy
127 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
114 114  (% class="western" lang="en-GB" %)
115 -(% lang="en-US" style="font-family:Calibri,serif" %)Adults
116 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
117 -(% class="western" lang="en-GB" %)
118 -(% lang="en-US" style="font-family:Calibri,serif" %)Youth
119 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
120 -(% class="western" lang="en-GB" %)
121 -(% lang="en-US" style="font-family:Calibri,serif" %)Children
122 -)))
123 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
124 -(% class="western" %)
125 125  
126 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
127 -(% class="western" %)
128 -
129 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
130 -(% class="western" %)
131 -
132 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
133 -(% class="western" %)
134 -
135 -)))
136 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
137 -(% class="western" lang="en-GB" style="text-align:center" %)
138 -(% lang="en-US" style="font-family:Calibri,serif" %)**Health status**
139 -)))
140 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
130 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
141 141  (% class="western" lang="en-GB" %)
142 -(% lang="en-US" style="font-family:Calibri,serif" %)Healthy
143 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
144 -(% class="western" lang="en-GB" %)
145 -(% lang="en-US" style="font-family:Calibri,serif" %)Patient
146 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
147 -(% class="western" lang="en-GB" %)
148 -(% lang="en-US" style="font-family:Calibri,serif" %)Rehabilitant
149 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
150 -(% class="western" lang="en-GB" %)
151 -(% lang="en-US" style="font-family:Calibri,serif" %)Recovered/Survivor
152 -)))
153 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
154 -(% class="western" %)
155 155  
156 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
157 -(% class="western" %)
158 -
159 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
160 -(% class="western" %)
161 -
162 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
163 -(% class="western" %)
164 -
165 -)))
166 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
167 -(% class="western" lang="en-GB" style="text-align:center" %)
168 -(% lang="en-US" style="font-family:Calibri,serif" %)**A specific disease, disorder or disability**
169 -)))
170 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
133 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
171 171  (% class="western" lang="en-GB" %)
172 -(% lang="en-US" style="font-family:Calibri,serif" %)ADHD
173 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
174 -(% class="western" lang="en-GB" %)
175 -(% lang="en-US" style="font-family:Calibri,serif" %)Dementia
176 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
177 -(% class="western" lang="en-GB" %)
178 -(% lang="en-US" style="font-family:Calibri,serif" %)Parkinsons’ disease
179 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
180 -(% class="western" lang="en-GB" %)
181 -(% lang="en-US" style="font-family:Calibri,serif" %)Loneliness and Social Isolation
182 -)))
183 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
184 -(% class="western" lang="en-GB" %)
185 -(% lang="en-US" style="font-family:Calibri,serif" %)Autism
186 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
187 -(% class="western" lang="en-GB" %)
188 -(% lang="en-US" style="font-family:Calibri,serif" %)Down syndrome
189 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
190 -(% class="western" lang="en-GB" %)
191 -(% lang="en-US" style="font-family:Calibri,serif" %)Physical disability
192 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
193 -(% class="western" lang="en-GB" %)
194 -(% lang="en-US" style="font-family:Calibri,serif" %)Mental health
195 -)))
196 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
197 -(% class="western" lang="en-GB" %)
198 -(% lang="en-US" style="font-family:Calibri,serif" %)Cardiovascular disease
199 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
200 -(% class="western" lang="en-GB" %)
201 -(% lang="en-US" style="font-family:Calibri,serif" %)Idiopathic pulmonary fibrosis (IPF)
202 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
203 -(% class="western" lang="en-GB" %)
204 -(% lang="en-US" style="font-family:Calibri,serif" %)Sleep apnea/apnea
205 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
206 -(% class="western" lang="en-GB" %)
207 -(% lang="en-US" style="font-family:Calibri,serif" %)Mild cognitive impairment
208 -)))
209 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
210 -(% class="western" lang="en-GB" %)
211 -(% lang="en-US" style="font-family:Calibri,serif" %)Chronic Obstructive Pulmonary Disease (COPD)
212 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
213 -(% class="western" lang="en-GB" %)
214 -(% lang="en-US" style="font-family:Calibri,serif" %)Language disability
215 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
216 -(% class="western" lang="en-GB" %)
217 -(% lang="en-US" style="font-family:Calibri,serif" %)Substance abuse (drugs, alcohol)
218 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
219 -(% class="western" lang="en-GB" %)
220 -(% lang="en-US" style="font-family:Calibri,serif" %)Multiple sclerosis
221 -)))
222 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)(((
223 -(% class="western" lang="en-GB" %)
224 -(% lang="en-US" style="font-family:Calibri,serif" %)Cognitive disorder (mild, major)
225 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
226 -(% class="western" lang="en-GB" %)
227 -(% lang="en-US" style="font-family:Calibri,serif" %)Intellectual disability/ Learning difficulty/ Mental retardation
228 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
229 -(% class="western" lang="en-GB" %)
230 -(% lang="en-US" style="font-family:Calibri,serif" %)Trauma patient
231 -
232 -(% class="western" lang="en-GB" %)
233 -(% lang="en-US" style="font-family:Calibri,serif" %)(e.g., a spinal cord injury)
234 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
235 -(% class="western" lang="en-GB" %)
236 -(% lang="en-US" style="font-family:Calibri,serif" %)Neurodegenerative diseases
237 -)))
238 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
239 -(% class="western" %)
240 240  
241 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
242 -(% class="western" %)
243 -
244 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
245 -(% class="western" %)
246 -
247 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
248 -(% class="western" %)
249 -
250 250  )))
251 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
252 -(% class="western" lang="en-GB" style="text-align:center" %)
253 -(% lang="en-US" style="font-family:Calibri,serif" %)**Clients of a specific service**
254 -)))
255 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
137 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)**
138 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Schizophrenia|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease
139 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Post-Stroke Patients with Moving or Linguistic Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Sleep Disorders: e.g., Apnea, Hypopnea|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
140 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
141 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)**
142 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
143 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
256 256  (% class="western" lang="en-GB" %)
257 -(% lang="en-US" style="font-family:Calibri,serif" %)Child welfare
258 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
259 -(% class="western" lang="en-GB" %)
260 -(% lang="en-US" style="font-family:Calibri,serif" %)Nursing home
261 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
262 -(% class="western" lang="en-GB" %)
263 -(% lang="en-US" style="font-family:Calibri,serif" %)Employment service
264 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
265 -(% class="western" %)
266 266  
267 -)))
268 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
146 +)))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
269 269  (% class="western" lang="en-GB" %)
270 -(% lang="en-US" style="font-family:Calibri,serif" %)Early childhood education
271 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
272 -(% class="western" lang="en-GB" %)
273 -(% lang="en-US" style="font-family:Calibri,serif" %)Home care
274 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
275 -(% class="western" lang="en-GB" %)
276 276  
277 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
149 +)))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
278 278  (% class="western" lang="en-GB" %)
279 279  
280 280  )))
281 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
282 -(% class="western" %)
283 -
284 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
285 -(% class="western" %)
286 -
287 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
288 -(% class="western" %)
289 -
290 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
291 -(% class="western" %)
292 -
293 -)))
294 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
295 -(% class="western" lang="en-GB" style="text-align:center" %)
296 -(% lang="en-US" style="font-family:Calibri,serif" %)**Vulnerable groups**
297 -)))
298 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)(((
153 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)**
154 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="text-align:justify; vertical-align:middle" %)Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
299 299  (% class="western" lang="en-GB" %)
300 -(% lang="en-US" style="font-family:Calibri,serif" %)Minors/Children
301 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
302 -(% class="western" lang="en-GB" %)
303 -(% lang="en-US" style="font-family:Calibri,serif" %)Single parents with minor children
304 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
305 -(% class="western" lang="en-GB" %)
306 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons subjected to psychological, physical or sexual violence
307 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
308 -(% class="western" lang="en-GB" %)
309 -(% lang="en-US" style="font-family:Calibri,serif" %)Substance users
310 -
311 -(% class="western" lang="en-GB" %)
312 -(% lang="en-US" style="font-family:Calibri,serif" %)(drugs, alcohol)
156 +Down Syndrome
313 313  )))
314 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
158 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Chronical Diseases: e.g., Persons With Chronic Pulmonary (Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Cardiological Or Other Conditions (Aphasia)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
315 315  (% class="western" lang="en-GB" %)
316 -(% lang="en-US" style="font-family:Calibri,serif" %)Disabled people
317 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
318 -(% class="western" lang="en-GB" %)
319 -(% lang="en-US" style="font-family:Calibri,serif" %)Victims of trafficking in human beings
320 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
321 -(% class="western" lang="en-GB" %)
322 -(% lang="en-US" style="font-family:Calibri,serif" %)Ethnic minorities and immigrants
323 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
324 -(% class="western" lang="en-GB" %)
325 -(% lang="en-US" style="font-family:Calibri,serif" %)Isolated people
160 +
326 326  )))
327 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
328 -(% class="western" lang="en-GB" %)
329 -(% lang="en-US" style="font-family:Calibri,serif" %)Elderly people
330 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
331 -(% class="western" lang="en-GB" %)
332 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons with serious illnesses
333 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
334 -(% class="western" lang="en-GB" %)
335 -(% lang="en-US" style="font-family:Calibri,serif" %)Homeless people
336 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
337 -(% class="western" lang="en-GB" %)
338 -(% lang="en-US" style="font-family:Calibri,serif" %)Ex-prisoners and people with criminal background
339 -)))
340 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
341 -(% class="western" lang="en-GB" %)
342 -(% lang="en-US" style="font-family:Calibri,serif" %)Pregnant women
343 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
344 -(% class="western" lang="en-GB" %)
345 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons with mental disorders
346 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
347 -(% class="western" lang="en-GB" %)
162 +
163 +:
164 +:
165 +: (% lang="en-US" %)Typical approaches to define (%%)//**professional **//end users in health and wellbeing living lab projects are presented in the following table .
166 +
167 +(((
168 +(% style="margin-left:auto; margin-right:auto; width:1694px" %)
169 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Informal Caregivers**
170 +|(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)Part of adults and citizens' group|(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)
171 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Health Care Professionals / Formal Caregivers**
172 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Doctors|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Social workers|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapists|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Psychologists
173 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Registered nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Practical nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Physicians|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
174 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Students**
175 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Medical|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Engineering|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Computer Science|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Pedagogues
176 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)English Literature|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Nursing|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapy|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Social Services
177 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Health Care Management|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
178 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Organizations**
179 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Hospitals|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Nursing homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Care homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Home care Organizations
180 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Network organizations|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Day care centers|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)
181 +
348 348  
349 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
350 -(% class="western" lang="en-GB" %)
351 -
352 352  )))
353 353  
185 +:
186 +
354 354  (% class="western" lang="en-GB" %)
355 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .
188 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) .
356 356  
357 -
358 358  |**Researcher expertise**|**Brief use case description**
359 -|Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making
360 -|Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)
361 -|Computer/Technology Scientists|Developing systems/tools/ technologies, testing and evaluating an ICT tool, prototype and real-life testing, computer vision & AI, Virtual Reality & Augmented Reality, Cybersecurity
362 -|(Clinical, social, developmental, neuro-) Psychologists|Studying the behaviour and the mental wellbeing of participants, conducting psychometrics evaluation and real-life setting experimentation/observation/real life testing
363 -|Social workers/researchers|Conducting an investigation in accordance with the scientific methods and tools, studying the impact of new care models and/or care innovations on society, developing models for a caring and inclusive society
364 -|Researchers with clinical expertise|(Doctors, nurses, healthcare workers, specialists, physiotherapists etc.), conducting research of healthcare services and practices, research on symptomatology or epidemiology of a disease, analysis of clinical effects of research performed in the study, e.g; via real life testing
365 -|Experts in UX research and assessment|Developing the process for user experience design (UXD, UED, or XD) supporting user behavior through usability, usefulness, and desirability provided in the interaction with a product or service, addressing all aspects as perceived by users with a focus on the quality of the user experience. Studying and experimenting the best practices for UI/UX and evaluating user’s experience in different situations and while using different tools
366 -|Experts in sport science|Experimenting novel training methods, and their effectiveness in various dimensions such as safety, engagement, and physical capabilities. Studying the impact of physical movements in various functions and wellbeing features
367 -|Experts in rehabilitation (physical, cognitive)|Physiology, physiotherapy, occupational health research, rehabilitation and prevention. Cognitive diseases assistive technology, neuromuscular rehabilitation assistive technology
368 -|Experts in performing arts|Creative health improvement (e.g. for cognitive decline) through music and dance (example: redesigning public spaces into healthy spaces: test and validate Smart methodologies, products and services through folk dance)
369 -|Business developers|Studying the product-market fit, matching a solution with a societal need, learning about the user acceptance of products and services, as well as about potential products to develop, willingness to pay, business model and ideal route to market
370 -|Pedagogues/educators|Evaluating different pedagogical approaches and their impact learning performance (especially in Simulation lab)
371 -|Experts in applied economics|Evaluating cost and performance in different healthcare processes, situations and public health
372 -|Experts in ergonomics and safety|Implementation and validation of ergonomic technologies/services to support workers and system performance, promoting ergonomics in working environments, improving both health/well-being and productivity, while avoiding occupational hazards
373 -|Citizen Scientists / users as co-researchers|User empowerment, training, design, analysis and implementation of strategies and methodologies for user engagement and for raising awareness and generating citizen participation
374 -|Biomedical researchers|Studying biochemical and physiological functions, investigating how the human body works with the aim of finding new ways to improve health. Biomedical engineering knowledge (Home hospitalization, Transitional Care, Multifunctional interaction), as well as digital biomarkers analysis (e.g. for cognitive state)
375 -|Experts in accessibility Design|Validating accessible Architectonics and escape route models with VR experiment and real-life simulations
376 -|Neuroscientists|Focusing on the brain and its impact on behaviour and cognitive functions (cognitive neuroscience, EEG-based BMI research, protocol / paradigm testing, study framework evaluation)
377 -|Innovation and design management researchers|Ecosystem and innovation management research, social network analysis. Evaluating how health and wellbeing ecosystem operates between different actors at local, regional, national and international level, including also scaling and commercialization
378 -|Experts in organizational studies|Co-creation, experimentation, organizational research, experts by experience / pier support included. Evaluation how multistakeholder collaboration and co-creation is done and how effective it is. Evaluates experimentations and experimentation culture. How users are involved into these processes
379 -|Data Scientists|Collecting, analysing and interpreting digital data, such as data analytics in healthcare and digital patient recordings (how patient information recording process is managed and utilized during the intervention by using digital tools in simulated situations)
191 +|(% style="vertical-align:middle" %)Citizen scientists, users as co-researchers|(% style="vertical-align:middle" %)User empowerment, training, design, analysis and implementation of strategies and methodologies for user engagement and for raising awareness and generating citizen participation.
192 +|(% style="vertical-align:middle" %)Computer, technology scientists|(% style="vertical-align:middle" %)Developing systems/tools/ technologies, testing and evaluating an ICT tool, prototype and real-life testing, computer vision & AI, Virtual Reality & Augmented Reality, Cybersecurity.
193 +|(% style="vertical-align:middle" %)Data scientists|(% style="vertical-align:middle" %)Collecting, analysing and interpreting digital data, such as data analytics in healthcare and digital patient recordings (how patient information recording process is managed and utilized during the intervention by using digital tools in simulated situations).
194 +|(% style="vertical-align:middle" %)Rehabilitation (physical, cognitive) experts|(% style="vertical-align:middle" %)Physiology, physiotherapy, occupational health research, rehabilitation and prevention. Cognitive diseases assistive technology, neuromuscular rehabilitation assistive technology.
195 +|(% style="vertical-align:middle" %)UX research and assessment experts|(% style="vertical-align:middle" %)Developing the process for user experience design (UXD, UED, or XD) supporting user behaviour through usability, usefulness, and desirability provided in the interaction with a product or service, addressing all aspects as perceived by users with a focus on the quality of the user experience. Studying and experimenting the best practices for UI/UX and evaluating user’s experience in different situations and while using different tools.
196 +|(% style="vertical-align:middle" %)Clinical expertise researchers|(% style="vertical-align:middle" %)(Doctors, nurses, healthcare workers, specialists, physiotherapists etc.), conducting research of healthcare services and practices, research on symptomatology or epidemiology of a disease, analysis of clinical effects of research performed in the study, e.g., via real life testing.
197 +|(% style="vertical-align:middle" %)Policymakers|(% style="vertical-align:middle" %)Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making.
198 +|(% style="vertical-align:middle" %)Biomedical researchers|(% style="vertical-align:middle" %)Studying biochemical and physiological functions, investigating how the human body works with the aim of finding new ways to improve health. Biomedical engineering knowledge (Home hospitalization, Transitional Care, Multifunctional interaction), as well as digital biomarkers analysis (e.g., for cognitive state).
199 +|(% style="vertical-align:middle" %)Business developers|(% style="vertical-align:middle" %)Studying the product-market fit, matching a solution with a societal need, learning about the user acceptance of products and services, as well as about potential products to develop, willingness to pay, business model and ideal route to market.
200 +|(% style="vertical-align:middle" %)Innovation and design management researchers|(% style="vertical-align:middle" %)Ecosystem and innovation management research, social network analysis. Evaluating how health and wellbeing ecosystem operates between different actors at local, regional, national and international level, including also scaling and commercialization.
201 +|(% style="vertical-align:middle" %)Accessibility design experts|(% style="vertical-align:middle" %)Validating accessible architectonics and escape route models with VR experiment and real-life simulations.
202 +|(% style="vertical-align:middle" %)Ergonomics and safety experts|(% style="vertical-align:middle" %)Implementation and validation of ergonomic technologies/services to support workers and system performance, promoting ergonomics in working environments, improving both health/well-being and productivity, while avoiding occupational hazards.
203 +|(% style="vertical-align:middle" %)Organizational studies experts|(% style="vertical-align:middle" %)Co-creation, experimentation, organizational research, experts by experience / pier support included. Evaluation how multistakeholder collaboration and co-creation is done and how effective it is. Evaluates experimentations and experimentation culture. How users are involved into these processes.
204 +|(% style="vertical-align:middle" %)Neuroscientists|(% style="vertical-align:middle" %)Focusing on the brain and its impact on behaviour and cognitive functions (cognitive neuroscience, EEG-based BMI research, protocol / paradigm testing, study framework evaluation).
205 +|(% style="vertical-align:middle" %)Psychologists (clinical, social, developmental, neuro)|(% style="vertical-align:middle" %)Studying the behaviour and the mental wellbeing of participants, conducting psychometrics evaluation and real-life setting experimentation/observation/real life testing.
206 +|(% style="vertical-align:middle" %)Social workers/researchers|(% style="vertical-align:middle" %)Conducting an investigation in accordance with the scientific methods and tools, studying the impact of new care models and/or care innovations on society, developing models for a caring and inclusive society.
207 +|(% style="vertical-align:middle" %)Sport science experts|(% style="vertical-align:middle" %)Experimenting novel training methods, and their effectiveness in various dimensions such as safety, engagement, and physical capabilities. Studying the impact of physical movements in various functions and wellbeing features.
208 +|(% style="vertical-align:middle" %)Communication studies experts|(% style="vertical-align:middle" %)Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab).
209 +|(% style="vertical-align:middle" %)Performing arts experts|(% style="vertical-align:middle" %)Creative health improvement (e.g., for cognitive decline) through music and dance (example: redesigning public spaces into healthy spaces: test and validate Smart methodologies, products and services through folk dance).
210 +|(% style="vertical-align:middle" %)Pedagogues/educators|(% style="vertical-align:middle" %)Evaluating different pedagogical approaches and their impact learning performance (especially in Simulation lab).
211 +|(% style="vertical-align:middle" %)Applied economics experts|(% style="vertical-align:middle" %)Evaluating cost and performance in different healthcare processes, situations and public health.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project